235 related articles for article (PubMed ID: 16489839)
1. Topical macrolide immunomodulators: a role in the treatment of vitiligo?
Tjioe M; Vissers WH; Gerritsen MJ
Am J Clin Dermatol; 2006; 7(1):7-12. PubMed ID: 16489839
[TBL] [Abstract][Full Text] [Related]
2. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.
Wollina U
Am J Clin Dermatol; 2007; 8(3):157-73. PubMed ID: 17492844
[TBL] [Abstract][Full Text] [Related]
3. New treatment modalities for vitiligo: focus on topical immunomodulators.
Kostovic K; Pasic A
Drugs; 2005; 65(4):447-59. PubMed ID: 15733009
[TBL] [Abstract][Full Text] [Related]
4. Topical pimecrolimus in the treatment of vitiligo.
Boone B; Ongenae K; Van Geel N; Vernijns S; De Keyser S; Naeyaert JM
Eur J Dermatol; 2007; 17(1):55-61. PubMed ID: 17324829
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical calcineurin inhibitors in vitiligo.
Wong R; Lin AN
Int J Dermatol; 2013 Apr; 52(4):491-6. PubMed ID: 23331250
[TBL] [Abstract][Full Text] [Related]
6. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
Hartmann A; Bröcker EB; Hamm H
J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical calcineurin inhibitors in lichen planus.
Samycia M; Lin AN
J Cutan Med Surg; 2012; 16(4):221-9. PubMed ID: 22784514
[TBL] [Abstract][Full Text] [Related]
8. Potential new indications of topical calcineurin inhibitors.
Luger T; Paul C
Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
[TBL] [Abstract][Full Text] [Related]
9. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
10. Topical tacrolimus and pimecrolimus: future directions.
Ling MR
Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
[TBL] [Abstract][Full Text] [Related]
11. Topical immunomodulators are effective for treatment of vitiligo.
Choi CW; Chang SE; Bak H; Choi JH; Park HS; Huh CH; Kim CW; Kim SE; Mun SK; Kim BJ; Kim MN
J Dermatol; 2008 Aug; 35(8):503-7. PubMed ID: 18789070
[TBL] [Abstract][Full Text] [Related]
12. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color.
Silverberg JI; Silverberg NB
J Drugs Dermatol; 2011 May; 10(5):507-10. PubMed ID: 21533297
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
[TBL] [Abstract][Full Text] [Related]
14. Off-Label Uses of Topical Calcineurin Inhibitors.
Wong E; Kurian A
Skin Therapy Lett; 2016 Jan; 21(1):8-10. PubMed ID: 27224898
[TBL] [Abstract][Full Text] [Related]
15. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of topical calcineurin inhibitors compared with topical corticosteroids in the treatment of vitiligo: A systematic review and meta-analysis.
Chang HC; Hsu YP; Huang YC
J Am Acad Dermatol; 2020 Jan; 82(1):243-245. PubMed ID: 31408687
[No Abstract] [Full Text] [Related]
17. Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors.
Elad S; Epstein JB; Yarom N; Drucker S; Tzach R; von Bültzingslöwen I
Expert Opin Emerg Drugs; 2010 Dec; 15(4):713-26. PubMed ID: 21091397
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of 0.1% topical tacrolimus in adult and children patients with vitiligo.
Udompataikul M; Boonsupthip P; Siriwattanagate R
J Dermatol; 2011 Jun; 38(6):536-40. PubMed ID: 21352308
[TBL] [Abstract][Full Text] [Related]
19. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo.
Abd-Elazim NE; Yassa HA; Mahran AM
J Cosmet Dermatol; 2020 Jun; 19(6):1447-1455. PubMed ID: 31668003
[TBL] [Abstract][Full Text] [Related]
20. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
